Pharmacology of neuroleptics in use in the United StatesRICHELSON, E.The Journal of clinical psychiatry. 1985, Vol 46, Num 8, pp 8-14, issn 0160-6689Article

Severe adverse drug reactions in psychiatric inpatients treated with neurolepticsBENDER, S; GROHMANN, R; ENGEL, R. R et al.Pharmacopsychiatry. Supplement. 2004, Vol 37, Num 1, pp S46-S53, issn 0936-9589Article

Trifluoperazine stimulates the coordinate degradation of sphingomyelin and phosphatidylcholine in GH₃ pituitary cellsKOLESNICK, R. N; HEMER, M. R.The Journal of biological chemistry (Print). 1989, Vol 264, Num 24, pp 14057-14061, issn 0021-9258, 5 p.Article

One-dimensional chemical shift imaging of fluorinated neuroleptics in rat brain in vivo by ¹⁹F NMR rotating frame zeugmatographyNAKADA, T; KWEE, I. L.Magnetic resonance imaging. 1989, Vol 7, Num 5, pp 543-545, issn 0730-725X, 3 p.Article

Determination of tiapride in plasma by high-performance liquid chromatographyNORMAN, T. R; JAMES, R. H; GREGORY, M. S et al.Journal of chromatography. 1986, Vol 375, Num 1, pp 197-201, issn 0021-9673Article

Chronic haloperidol during development attenuates dopamine autoreceptor function in striatal and mesolimbic brain regions of young and older adult ratsSCALZO, F. M; SPEAR, L. P.Psychopharmacologia. 1985, Vol 85, Num 3, pp 271-276, issn 0033-3158Article

Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenic out-patients: clinical outcome at one yearJOLLEY, A. G; HIRSCH, S. R; MCRINCK, A et al.British medical journal (1857). 1989, Vol 298, Num 6679, pp 987-990, issn 0007-1447, 4 p.Article

How do psychiatrists choose among different antipsychotics?HAMANN, Johannes; KOLBE, Grit; COHEN, Rudolf et al.European journal of clinical pharmacology. 2005, Vol 61, Num 11, pp 851-854, issn 0031-6970, 4 p.Article

Hyperglycemia associated with antipsychotic treatment in a multicenter drug safety projectKROPP, S; GROHMANN, R; HAUSER, U et al.Pharmacopsychiatry. Supplement. 2004, Vol 37, Num 1, pp S79-S83, issn 0936-9589Article

Le syndrome malin des neuroleptiques = Neuroleptic malignant syndromeDELACOUR, J. L; WAGSCHAL, G; DAOUDAL, P et al.Réanimation, soins intensifs, médecine d'urgence. 1985, Vol 1, Num 3, pp 173-178, issn 0765-5290Article

The Pisa syndrome: a report of two casesYASSA, R.British journal of psychiatry (Print). 1985, Vol 146, pp 93-95, issn 0007-1250, INDEXArticle

Differential effects of apomorphine on spinal reflex activity following 5-hydroxydopamine or long-term haloperidol pretreatmentJENSEN, T. S; CHRISTENSEN, N. J; SMITH, D. F et al.Journal of neural transmission. 1986, Vol 65, Num 2, pp 125-134, issn 0300-9564Article

Neuroleptiques et antipsychotiquesPETIT, Marion; LLORCA, Pierre-Michel.La Revue du praticien. Médecine générale. 2007, Num 780-781, pp 780-782, issn 0989-2737, 3 p.Article

Pharmacogenetics of antipsychotic-induced weight gainCORRELL, Christoph U; MALHOTRA, Anil K.Psychopharmacologia. 2004, Vol 174, Num 4, pp 477-489, issn 0033-3158, 13 p.Article

The Pharmacokinetics of ZiprasidoneTANDON, R.British journal of clinical pharmacology. Supplement. 2000, Vol 49, Num 1, issn 0264-3774, 78 p.Serial Issue

Les neuroleptiques ou antipsychotiques = Neuroleptics and antipsychoticsDRESSE, A.RMLG. Revue médicale de Liège. 1996, Vol 51, Num 1, pp 65-69, issn 0370-629XArticle

Neuroleptic prescriptions for acutely ill geriatric patientsHESSE, K. A; DRISCOLL, A; JACOBSON, S et al.Archives of internal medicine (1960). 1993, Vol 153, Num 22, pp 2581-2587, issn 0003-9926Article

Neuroleptiques atypiques et nouveaux antipsychotiques = Atypical neuroleptics and related new antipsychoticsDENIKER, P.L' Encéphale (Paris). 1990, Vol 16, Num 2, pp 61-62, issn 0013-7006, 2 p.Article

Sindrome maligno por neurolépticos = Syndrome malin dû aux neuroleptiques = Neuroleptic malignant syndromRODRIGUEZ ROLDAN, J. M; MIRA SANCHEZ, L. E; MARTINEZ FRESNEDA, M et al.Medicina intensiva (Madrid. Ed. impresa). 1989, Vol 13, Num 2, pp 58-60, issn 0210-5691Article

Syndrome malin des neuroleptiques dû au tiapride et complications neurologiques = Tiapride-induced neuroleptic malignant syndrome and neurological complicationsPEREZ, Y; DE LACHARRIERE, O; VALCKE, J. C et al.La Presse médicale (1983). 1989, Vol 18, Num 11, issn 0755-4982, 585 [1 p.]Article

Human scalp hair as evidence of individual dosage history of haloperidol : method and retrospective studyUEMATSU, T; SATO, R; SUZUKI, K et al.European journal of clinical pharmacology. 1989, Vol 37, Num 3, pp 239-244, issn 0031-6970, 6 p.Article

Neuroleptic rechallenge after neuroleptic malignant syndrome: case report and literature reviewWELLS, A. J; SOMMI, R. W; CRISMON, M. L et al.Drug intelligence & clinical pharmacy. 1988, Vol 22, Num 6, pp 475-480, issn 0012-6578Article

Exposés/Dyskinésies tardives: évaluation des données actuelles, colloque, Casablanca, MAR, 15-16 octobre 1987L' Encéphale (Paris). 1988, Vol 14, pp 153-269, issn 0013-7006, no spécialConference Proceedings

Atypical antipsychotic drugs : Clinical and preclinical studiesFATEMI, H. S; MELTZER, H. Y; ROTH, B. L et al.Handbook of experimental pharmacology. 1996, Vol 120, pp 77-115, issn 0171-2004Article

Bien prescrire les psychotropes. I : Les neuroleptiquesPOCHAT, M. D; LEMOINE, P.Concours médical (Paris). 1991, Vol 113, Num 37, pp 3333-3338, issn 0010-5309, 5 p.Article